Dana-Farber Launches Center for RAS Therapeutics to Target the RAS Oncogene in Cancer By Admin 6 Jan, 2025
First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-Farber By Admin 15 Nov, 2024
Specially Equipped Natural Killer Cells Show Effectiveness Against the Most Common Form of Ovarian Cancer By Admin 12 Jul, 2024
Dana-Farber Research Findings Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) By Admin 1 Jun, 2024
